Genetic testing in PAH: assessing clinical risk and prognostic significance of mutations

11 May 2024 (08:00 - 20:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Marta Vilela

Hospital De Santa Maria, Lisbon (Portugal)

7 More presentations in this session

Presentation thumbnail

Relationship between dynamics of cardiac sympathetic innervation, assessed with 123I-MIBG SPECT, exercise capacity and left ventricular reverse remodelling in dilated cardiomyopathy

Doctor E. Dziewiecka (Krakow, PL)

Abstract Slides Video

Presentation thumbnail

The genetic architecture of dilated cardiomyopathy in Hungary: analysis of 135 patients with a panel of 98 genes

Doctor H. Takacs (Szeged, HU)

Abstract Slides Video

Presentation thumbnail

Prevalence and predictors of normotensive cardiogenic shock in intermediate-high risk pulmonary embolism.

Doctor B. Lacerda Teixeira (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Hyponatremia as a predictor of short-term mortality in patients with pulmonary embolism

Doctor J. Gouveia Fiuza (Viseu, PT)

Abstract Slides Video

Presentation thumbnail

PERFORM score: a predictive prognostic tool for anticipating the requirement for fibrinolysis in pulmonary embolism

Doctor M. Duarte Almeida (Viseu, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Myocardial disease - clinical 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

You may be interested in

Congress Presentation

Genetic testing in pulmonary hypertension in adults and children

Congress Presentation

Risk in pulmonary hypertension ''beyond the prognostic tools of the guidelines"

Congress Presentation

Exploring and managing pulmonary hypertension in congenital heart defects: a challenging path

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources